For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) was $8.15 for the day, down -1.81% from the previous closing price of $8.3. In other words, the price has decreased by -$1.81 from its previous closing price. On the day, 1.07 million shares were traded. AMLX stock price reached its highest trading level at $8.3 during the session, while it also had its lowest trading level at $8.06.
Ratios:
Our analysis of AMLX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.05 and its Current Ratio is at 12.05. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.00.
On June 24, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $17.
On June 17, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $12.Citigroup initiated its Buy rating on June 17, 2025, with a $12 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 31 ’25 when FRATES JAMES M sold 10,896 shares for $3.47 per share. The transaction valued at 37,806 led to the insider holds 290,988 shares of the business.
Bedrosian Camille L sold 12,425 shares of AMLX for $43,082 on Mar 31 ’25. The Chief Medical Officer now owns 194,375 shares after completing the transaction at $3.47 per share. On Mar 31 ’25, another insider, Mazzariello Gina, who serves as the Chief Legal Officer of the company, sold 9,192 shares for $3.48 each. As a result, the insider received 31,954 and left with 187,969 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AMLX now has a Market Capitalization of 726499968 and an Enterprise Value of 523813856. Its current Enterprise Value per Revenue stands at -411.803 whereas that against EBITDA is -2.533.
Stock Price History:
The Beta on a monthly basis for AMLX is -0.44, which has changed by 3.2010307 over the last 52 weeks, in comparison to a change of 0.16932249 over the same period for the S&P500. Over the past 52 weeks, AMLX has reached a high of $8.72, while it has fallen to a 52-week low of $1.76. The 50-Day Moving Average of the stock is 31.83%, while the 200-Day Moving Average is calculated to be 73.05%.
Shares Statistics:
AMLX traded an average of 1.46M shares per day over the past three months and 1533640 shares per day over the past ten days. A total of 89.08M shares are outstanding, with a floating share count of 66.23M. Insiders hold about 26.74% of the company’s shares, while institutions hold 78.47% stake in the company. Shares short for AMLX as of 1752537600 were 7466420 with a Short Ratio of 5.12, compared to 1749772800 on 4039910. Therefore, it implies a Short% of Shares Outstanding of 7466420 and a Short% of Float of 9.24.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
